PlainRecalls
FDA Drug Moderate Class II Ongoing

Triple SupremeZen Plus 3500, packaged in cardboard blisters containing one capsule per card, Distributed by Yolo Studio, Cliffside Park, NJ

Reported: May 26, 2021 Initiated: April 6, 2021 #D-0383-2021

Product Description

Triple SupremeZen Plus 3500, packaged in cardboard blisters containing one capsule per card, Distributed by Yolo Studio, Cliffside Park, NJ

Reason for Recall

Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.

Details

Recalling Firm
Hyobin LLC
Units Affected
300 cards
Distribution
USA Nationwide
Location
Ridgewood, NJ

Frequently Asked Questions

What product was recalled?
Triple SupremeZen Plus 3500, packaged in cardboard blisters containing one capsule per card, Distributed by Yolo Studio, Cliffside Park, NJ. Recalled by Hyobin LLC. Units affected: 300 cards.
Why was this product recalled?
Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 26, 2021. Severity: Moderate. Recall number: D-0383-2021.